Skip to main content
11/07/2023

Dr. Sara Marsal wins a trifermed award for Social Impact in Healthcare

Dra. Sara Marsal

Dr. Sara Marsal.

11/07/2023

The head of the Rheumatology Service at Vall d'Hebron University Hospital and of the Rheumatology research group at VHIR is a highly accomplished rheumatologist with a distinguished career in the field.

Dr. Sara Marsal, head of the Rheumatology Service at Vall d'Hebron University Hospital and of the Rheumatology research group at Vall d'Hebron Research Institute (VHIR), has received a trifermed Award for Social Impact in Healthcare. The trifermed Awards aim to recognize individuals and organizations that are dedicated to improving the quality of health and making a positive impact on society.

Dr. Sara Marsal is a highly accomplished rheumatologist with a distinguished career in the field. She completed her medical studies at the University of Navarra and earned a doctoral degree from the University of Barcelona.

In 2000, Dr. Marsal founded the Rheumatology Research Group at VHIR, focusing on immune-mediated inflammatory diseases (IMID). Her groundbreaking research using omics technologies has been published in renowned biomedical journals, identifying novel therapeutic targets and molecular profiles related to IMID diagnosis and treatment response. She holds co-invented patents in the field of precision medicine for IMID.

She leads the IMID Consortium, a network of leading clinical researchers in rheumatology, dermatology, and gastroenterology, focused on molecular characterization of IMID through multiomic approaches. Dr. Marsal also directs the IMID-Biobank at VHIR, housing a substantial collection of unique biological samples from IMID patients.

In 2015, Dr. Marsal co-founded IMIDomics, a biotechnology spin-off from VHIR specializing in innovative target identification and precision medicine for IMID. She also coordinates a prestigious European H2020 project on combination therapies for IMID using systems biology.

Dr. Sara Marsal’s dedication to advancing medical knowledge and improving patient care has established her as an influential figure in rheumatology. Her exceptional achievements, research endeavors, and leadership roles demonstrate her commitment to enhancing the understanding and treatment of immune-mediated inflammatory diseases.

In words of Dra. Marsal, “thank you very much for this special award. I am very happy and honored to be recognized for my work in improving the quality of healthcare in our society. I am motivated by the passion and desire to make the world a better place, and I am grateful to be part of a community of people who share this goal. Once again, thank you very much”.

Related news

It is the first international multi-centre clinical trial to analyse the safety and effect of this treatment for an autoimmune disease.

Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.

Lesions present low levels of miR-885-5p, and this increases keratinocyte proliferation, the attraction of inflammatory cells and also the production of inflammatory mediators.

Related professionals

Sara Marsal Barril

Sara Marsal Barril

Main researcher
Rheumatology
Read more
Ernesto Trallero Araguas

Ernesto Trallero Araguas

Main researcher
Rheumatology
Read more
Ares Selles Rius

Ares Selles Rius

Research technician
Rheumatology
Read more
Érica Téllez Caballero

Érica Téllez Caballero

Research technician
Rheumatology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.